News

Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. 

Cook Medical SCAI CIVIC PRESERVE Clincal Studies Vena Cava Filter

Cook Medical is engaged in two clinical studies that will provide additional data on the safety and effectiveness of inferior vena cava (IVC) filters.

Argon Medical OptionElite retrievable inferior vena cava (IVC) filter guidewire

Argon Medical Devices Inc. received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing the OptionElite retrievable inferior ...

Angiotech Vena Cava Filter

One venous puncture, rather than two, is a safe and effective approach to intravascular ultrasound-guided inferior vena cava filter placement in critically-ill patients according to a new study...

Continuing its commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices Inc. launched the OptionELITE Retrievable ...

July 20, 2012 — Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior...

June 28, 2012 — BiO2 Medical Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colo., announced...

April 6, 2012 — Crux Biomedical announced that a recently completed pivotal trial of its Crux Vena Cava Filter (VCF) System with bi-directional retrieval was presented at the 2012 Society of...

January 27, 2012 — Crux Biomedical announced it received CE mark approval for its inferior vena cava filter (IVCF) with bi-directional retrieval (BDR).  Vena cava filters are designed to trap...

November 23, 2011 – Many specialists question whether a permanent inferior vena cava (IVC) filter can be developed where it does not have to be retrieved from the patient.

March 15, 2011 – Argon Medical Devices has entered into a definitive license agreement with Rex Medical, for exclusive global rights to market and distribute the Option Retrievable Inferior Vena...

July 15, 2010 – The first patient has enrolled in the Retrieve 2 U.S. trial, which will evaluate the safety and efficacy of Crux Biomedical's new Vena Cava Filter (VCF). The Crux VCF is a...

March 23, 2010 – A femoral access delivery system to aid physicians placing inferior vena cava (IVC) filters was introduced last week at the Society of Interventional Radiology (SIR) Annual...

October 21, 2009 – Cook Medical is introducing six new products in parallel to provide better treatment options to treat peripheral arterial disease (PAD), including new microwires, stents and...

September 22, 2009 – Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced...

July 21, 2009 – Total procedures performed in angio labs from 2004 to 2008 grew 20 percent, from 4 million in 2004 to 4.8 million procedures in 2008 for hospitals with 150 plus beds, resulting in...

June 8, 2009 - Angiotech Pharmaceuticals Inc. today said the FDA granted 510(k) clearance for the Option Inferior Vena Cava (IVC) Filter for use in both permanent and retrievable indications....

May 22, 2009 - Rafael Medical Technologies Inc. said this week it received FDA clearance for its SafeFlo Vena Cava Filter.

The clearance is for the permanent implantation of the filter in...

July 30, 2007 – The FDA gave Cook Medical, a developer of IVC filters, clearance for a permanent indication for its newest vena cava filter, Celect, which is designed to offer physicians a tool...